Recessive mutations in the neuronal isoforms of DST, encoding dystonin, lead to abnormal actin cytoskeleton organization and HSAN type VI.


Journal

Human mutation
ISSN: 1098-1004
Titre abrégé: Hum Mutat
Pays: United States
ID NLM: 9215429

Informations de publication

Date de publication:
01 2019
Historique:
received: 12 07 2018
revised: 22 09 2018
accepted: 25 10 2018
pubmed: 30 10 2018
medline: 7 3 2020
entrez: 30 10 2018
Statut: ppublish

Résumé

Hereditary sensory and autonomic neuropathies (HSAN) are clinically and genetically heterogeneous disorders, characterized by a progressive sensory neuropathy often complicated by ulcers and amputations, with variable motor and autonomic involvement. Several pathways have been implicated in the pathogenesis of neuronal degeneration in HSAN, while recent observations point to an emerging role of cytoskeleton organization and function. Here, we report novel biallelic mutations in the DST gene encoding dystonin, a large cytolinker protein of the plakin family, in an adult form of HSAN type VI. Affected individuals harbored the premature termination codon variant p.(Lys4330*) in trans with the p.(Ala203Glu) change affecting a highly conserved residue in an isoform-specific N-terminal region of dystonin. Functional studies showed defects in actin cytoskeleton organization and consequent delayed cell adhesion, spreading and migration, while recombinant p.Ala203Glu dystonin loses the ability to bind actin. Our data aid in the clinical and molecular delineation of HSAN-VI and suggest a central role for cell-motility and cytoskeletal defects in its pathogenesis possibly interfering with the neuronal outgrowth and guidance processes.

Identifiants

pubmed: 30371979
doi: 10.1002/humu.23678
doi:

Substances chimiques

Actins 0
Dystonin 0
Protein Isoforms 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-114

Subventions

Organisme : University of L'Aquila
Pays : International
Organisme : Italian Ministry of Health
ID : Ricerca Finalizzata
Pays : International
Organisme : Italian Ministry of Health
ID : Ricerca Corrente 2018-2020
Pays : International
Organisme : OsteoPath
ID : 01EC1006A
Pays : International
Organisme : DIMEOs
ID : 1EC1402B
Pays : International
Organisme : German Federal Ministry of Education and Research
Pays : International
Organisme : "Undiagnosed Disease Network Italy (UDN-Italy)"
ID : grant PGR00229-PGR00919
Pays : International

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Paola Fortugno (P)

Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.

Francesco Angelucci (F)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Gianluca Cestra (G)

IBPM, Istituto di Biologia e Patologia Molecolari, CNR, Rome, Italy.
Deptartment of Biology and Biotechnology, University of Rome "Sapienza,", Rome, Italy.

Letizia Camerota (L)

Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Angelo Salvatore Ferraro (AS)

Servizio di Immunoematologia e Medicina Trasfusionale, Policlinico Tor Vergata, Rome, Italy.

Sonia Cordisco (S)

Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Luigi Uccioli (L)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.

Daniele Castiglia (D)

Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.

Barbara De Angelis (B)

Department of Plastic and Reconstructive Surgery, University of Rome "Tor Vergata,", Rome, Italy.

Ingo Kurth (I)

Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen, Germany.

Uwe Kornak (U)

Institut für Medizinische Genetik und Humangenetik and Berlin-Brandenburg Center for Regenerative Therapies, Charité, Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
FG Development and Disease, Max-Planck-Institut fuer Molekulare Genetik, Berlin, Germany.

Francesco Brancati (F)

Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH